Adeshwar Meditex Ltd
Fundamental Score
Adeshwar Meditex Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ADESHWAR across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 12.34 vs Industry: 45.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Conservative Debt Levels (D/E: 0.16)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (5.25x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (57.55%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
8 factors identified
Below-Average Return on Equity (5.51%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.27%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-18.89%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-26.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Earnings Growth (-19.37% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-1.36% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Adeshwar Meditex Ltd
About ADESHWAR
Business Overview
Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, including eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP brand, rolled cotton bandages, absorbent cotton wool, abdominal pads, gauze swabs, and triangular bandages. It also provides plasters comprising elastic adhesive bandages under the A + M PLAST brand, cohesive bandages under the GLUBAN brand, adhesive tapes under the M Tape brand, microporous tapes under the AMPORE brand, synthetic casts, plaster of paris bandages under the A + MEDISET brand, capsicum belladonna perforated plasters, and cotton crepe bandages under the A + M CREPE brand; antiseptics/disinfectants under the BIODEX-C, BIO CLEAN, VILON-N, Pividine, Pividine-S, BENZ VETOL, Pividine-C, and BID QUAT brands; examination gloves and medical kits, surgical blades and blood lancets. In addition, it offers medical bandages including elastic, adhesive and non-adhesive tapes, such as medicated and non-medicated, military dressings, medicated and non-medicated, orthopedic bandages, soft products and equipment, sanitary napkins, infusion sets and allied products, antiseptic solutions, disinfectants, hand sanitizers, ointments, medicated and non-medicated, rectified spirit, extra neutral ethyl alcohol, and alcohol based products, sterile home based newborn and other kits, face masks, caps, gowns, face shield, PPE kits, HIV kits, all hospital protective wears and disposables, laboratory reagents, and testing kits. It serves hospitals, medical centers, households, and schools; and automobile and defense industries. The company was founded in 1951 and is based in Mumbai, India.
Company Details
Key Leadership
ADESHWAR Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Adeshwar Meditex Ltd (ADESHWAR)?
As of 29 Jan 2026, 10:32 am IST, Adeshwar Meditex Ltd (ADESHWAR) is currently trading at ₹21.00. The stock has a market capitalization of ₹25.54 (Cr).
Is ADESHWAR share price Overvalued or Undervalued?
ADESHWAR is currently trading at a P/E ratio of 12.34x, compared to the industry average of 45.95x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Adeshwar Meditex Ltd share price?
Key factors influencing ADESHWAR's price include its quarterly earnings growth (Sales Growth: -26.50%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Adeshwar Meditex Ltd a good stock for long-term investment?
Adeshwar Meditex Ltd shows a 5-year Profit Growth of -1.36% and an ROE of 5.51%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.16 before investing.
How does Adeshwar Meditex Ltd compare with its industry peers?
Adeshwar Meditex Ltd competes with major peers in the Healthcare Research, Analytics & Technology. Investors should compare ADESHWAR's P/E of 12.34x and ROE of 5.51% against the industry averages to determine its competitive standing.
What is the P/E ratio of ADESHWAR and what does it mean?
ADESHWAR has a P/E ratio of 12.34x compared to the industry average of 45.95x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹12 for every ₹1 of annual earnings.
How is ADESHWAR performing according to Bull Run's analysis?
ADESHWAR has a Bull Run fundamental score of 29.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ADESHWAR belong to?
ADESHWAR operates in the Healthcare Research, Analytics & Technology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Adeshwar Meditex Ltd.
What is Return on Equity (ROE) and why is it important for ADESHWAR?
ADESHWAR has an ROE of 5.51%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Adeshwar Meditex Ltd generates profits from shareholders' equity.
How is ADESHWAR's debt-to-equity ratio and what does it indicate?
ADESHWAR has a debt-to-equity ratio of 0.16, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ADESHWAR's dividend yield and is it a good dividend stock?
ADESHWAR offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ADESHWAR grown over the past 5 years?
ADESHWAR has achieved 5-year growth rates of: Sales Growth 8.33%, Profit Growth -1.36%, and EPS Growth -19.37%.
What is the promoter holding in ADESHWAR and why does it matter?
Promoters hold 57.55% of ADESHWAR shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ADESHWAR's market capitalization category?
ADESHWAR has a market capitalization of ₹26 crores, placing it in the Small-cap category.
How volatile is ADESHWAR stock?
ADESHWAR has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ADESHWAR?
ADESHWAR has a 52-week high of ₹N/A and low of ₹N/A.
What is ADESHWAR's operating profit margin trend?
ADESHWAR has a 5-year average Operating Profit Margin (OPM) of 6.09%, indicating the company's operational efficiency.
How is ADESHWAR's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -26.50% and YoY Profit Growth of -18.89%.
What is the institutional holding pattern in ADESHWAR?
ADESHWAR has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.